DA
ACGN

DCM Advisors’s Aceragen Inc ACGN Stock Holding History

DCM Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,183
Closed -$108K – 332
2021
Q3 		$108K Buy
+6,183
New +$112K 0.04% 253

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM Advisors's ACGN Position: Q4 2021 in Review

DCM Advisors sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 6,183 shares — an estimated $108K sold.

DCM Advisors first reported a position in ACGN in Q3 2021 and held it in 1 quarter. The position peaked at $108K in Q3 2021. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

  • DCM Advisors reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
  • DCM Advisors sold 6,183 Aceragen Inc shares in Q4 2021, an estimated $108K.
  • DCM Advisors first reported a position in Aceragen Inc in Q3 2021 and held it in 1 quarter.
  • DCM Advisors's Aceragen Inc position peaked at $108K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on DCM Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.